Income Statement Balance Sheet Cash Flow Statement
Annual Financials for AVEO Pharmaceuticals Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 20.72M 44.68M 164.85M 19.29M 1.29M
Cost of Goods Sold (COGS) incl. D&A 1.29M 1.35M - - -
COGS excluding D&A 0 0 - - -
Depreciation & Amortization Expense 1.29M 1.35M 1.65M 2.51M 3.78M
Depreciation 1.29M 1.35M - 2.51M 3.78M
Amortization of Intangibles 0 0 - 0 0
Gross Income 19.43M 43.33M - - -
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 60.62M 99.76M 129.25M 125.78M 93.41M
Research & Development 51.79M 86.35M 101.74M 91.36M 68.47M
Other SG&A 8.83M 13.41M 27.51M 34.42M 24.94M
Other Operating Expense 0 0 0 0 0
Unusual Expense 332,966 0 0 2.63M 8.12M
EBIT after Unusual Expense (332,966) 0 0 (2.63M) (8.12M)
Non Operating Income/Expense 0 900,000 10,000 247,000 (23,000)
Non-Operating Interest Income 144,258 126,000 527,000 497,000 125,000
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 2.81M 3.39M 3.84M 3.5M 3.13M
Gross Interest Expense 2.81M 3.39M 3.84M 3.5M 3.13M
Interest Capitalized 0 0 0 0 0
Pretax Income (44.19M) (58.79M) 30.65M (114.39M) (107.03M)
Income Tax (100,056) 0 0 0 0
Income Tax - Current Domestic (100,056) 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (44.09M) (58.79M) 30.65M (114.39M) (107.03M)
Minority Interest Expense 0 0 0 0 0
Net Income (44.09M) (58.79M) 30.65M (114.39M) (107.03M)
Extraordinaries & Discontinued Operations - 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets - 0 0 0 0
Cumulative Effect - Accounting Chg - - 0 0 0
Discontinued Operations - 0 0 0 0
Net Income After Extraordinaries (44.09M) (58.79M) 30.65M (114.39M) (107.03M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (44.09M) (58.79M) 30.65M (114.39M) (107.03M)
EPS (Basic) (1.49) (2.30) 0.77 (2.64) (2.10)
Basic Shares Outstanding 29.62M 25.58M 39.72M 43.37M 50.93M
EPS (Diluted) (1.49) (2.30) 0.74 (2.64) (2.10)
Diluted Shares Outstanding 29.62M 25.58M 41.47M 43.37M 50.93M
EBITDA (39.9M) (55.08M) 35.6M (106.49M) (92.11M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.